Actelion is committed to Pulmonary Arterial Hypertension (PAH) with Tracleer®(bosentan), an oral endothelin receptor antagonist (PAH WHO FC II, III, IV), Ventavis®(iloprost) an inhaled prostacyclin (NYHA Class III and IV PAH), and Veletri® (epoprostenol for injection) NYHA Class III or IV PPH and PH/SSc.
Tracleer®(bosentan), Ventavis®(iloprost), and Veletri®(epoprostenol for injection)
Pharmaceuticals Therapeutic Medications
Back to the Search
Msg #970:Copyright 2013-14 © a2z, Inc. All rights reserved.